Midi Health vs Rugiet Health
Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Midi Health vs Rugiet Health: Overview
Choosing between Midi Health and Rugiet Health for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. Rugiet Health also provides both semaglutide and tirzepatide at $87/month with a 7.6/10 rating.
The price difference of $77/month is significant - Rugiet Health is the more budget-friendly option, while Midi Health positions itself as a premium service.
Our recommended brand
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
At a glance
Price Difference
$77/mo
Rating Difference
1.0
Winner
Midi Health
Best For
Quality
Midi Health
View full Midi Health review →Rating
8.6/10Better
Monthly Price
$164
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s
Pros
- ✓The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
- ✓Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
- ✓Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
- ✓Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
- ✓There is no membership fee. You pay for care and medication only
- ✓Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
- ✓Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
- ✓The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
- ✓Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
- ✓Available in all 50 states
Cons
- ✗The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
- ✗Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
- ✗Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
- ✗Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
- ✗Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
- ✗Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
- ✗The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
- ✗GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Rugiet Health
View full Rugiet Health review →Rating
7.6/10
Monthly Price
$87Cheaper
Medications
sildenafiltadalafilapomorphineparoxetineenclomiphene
Pros
- ✓The compounded disclosure is exactly right and sits on the product page itself: 'Ready is a compounded drug product and requires a prescription. Compounded drugs are not approved by FDA and do not undergo review or verification by FDA for safety, effectiveness, or quality.' This is the clearest regulatory statement we have seen from any compounded-medication brand
- ✓A named nine-person Medical Advisory Board, mostly board-certified urologists, plus a named Chief Medical Officer - real, checkable clinical governance rather than an anonymous 'medical team'
- ✓Roughly 2,000 Trustpilot reviews at 4.3, with 100% of negative reviews answered, typically inside 24 hours
- ✓It publishes its own pricing article stating Ready starts at $7.29 per dose, and explains that the exact figure depends on the concentration prescribed (checked July 28, 2026)
- ✓Efficacy claims carry disclosed methodology - the onset figure is footnoted to a survey of 101 customers and another to 114 active patients in May 2025. The samples are small, but the sourcing is stated rather than hidden
- ✓Enclomiphene is marked 'Labs Required', so at least one product line has a genuine bloodwork gate rather than symptom-only prescribing
- ✓It states plainly that most insurance does not cover compounded medications, instead of implying coverage might apply
- ✓HSA/FSA eligible, free doctor consultation and shipping included, and a mobile app is available
- ✓Published phone support Monday to Friday plus Saturday hours, which is broader than most competitors
Cons
- ✗Ready stacks two PDE5 inhibitors - sildenafil and tadalafil - in a single dose, alongside apomorphine. No FDA-approved product combines two PDE5 inhibitors, and doubling the same mechanism compounds the blood-pressure-lowering effect without established additional benefit
- ✗Apomorphine is a dopamine agonist whose US approval is for 'off' episodes in advanced Parkinson's disease. Using it for arousal is off-label, and it independently causes nausea, low blood pressure and sudden sleep onset - risks that stack with the two PDE5 inhibitors
- ✗No price appears anywhere on the product pages, the treatment catalogue or the intake funnel. The only published figure sits in a blog post, so a shopper following the normal path has to create an account before learning what anything costs
- ✗Pricing is per dose rather than a flat monthly fee, so the monthly figure shown here reflects 12 doses at the $7.29 starting rate for comparison against similarly sold products. Your real cost depends on the concentration prescribed and how often you use it
- ✗'Up to 3x the power of generics' and 'delivers stronger, more reliable results than sildenafil or tadalafil alone' are comparative efficacy claims with no trial cited
- ✗The headline results - 85% feeling more confident, 80% preferring Rugiet - come from internal surveys of around 101 to 114 of the company's own customers, not controlled studies
- ✗Go Long combines paroxetine, an SSRI, with ED medication for premature ejaculation. SSRIs are used off-label for this, and paroxetine carries its own discontinuation and sexual side-effect profile
- ✗The '500k+ men choose Rugiet' figure is the company's own with no independent corroboration
- ✗Anyone taking nitrates or riociguat must not use these products, and the apomorphine component adds a serious interaction with 5-HT3 anti-emetics such as ondansetron
Feature-by-feature comparison
| Feature | Midi Health | Rugiet Health |
|---|---|---|
| Monthly Price | $164 | $87 |
| Rating | 8.6/10 | 7.6/10 |
| Medications | compounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1s | sildenafil, tadalafil, apomorphine, paroxetine, enclomiphene |
| Insurance Accepted | Yes | No |
| Support Hours | Not published | Monday to Friday 8:30am-5:30pm CT, Saturday 11am-4pm CT |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Discreet shipping included in every quoted medication price | Discreet delivery; free shipping included in subscription plans |
| Mobile App | No | Available |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Continued care visits with the same clinician, covered by insurance for qualifying patients | Ongoing provider access through the platform and app; cadence not published |
| Money-back Guarantee | None published | None published |
| Cancellation Policy | No membership fee and no subscription lock-in; you pay for care and medication only | Subscription based; buy 2 months of Ready and get the 3rd free promotion running at time of review |
Which should you choose?
Choose Midi Health if you:
- →Prefer a higher-rated service (8.6/10 vs 7.6/10)
- →Need insurance coverage for your treatment
- →Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)
Choose Rugiet Health if you:
- →Want to save $77/month with a more affordable option
- →Want more medication options to choose from
- →Value: the compounded disclosure is exactly right and sits on the product page itself: 'ready is a compounded drug product and requires a prescription. compounded drugs are not approved by fda and do not undergo review or verification by fda for safety, effectiveness, or quality.' this is the clearest regulatory statement we have seen from any compounded-medication brand
Website previews
Midi Health
Rugiet Health
Our recommendation
Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi HealthRelated comparisons
Midi Health vs CoreAge Rx
$164
★ 8.6
vs
$99
★ 9.6
Midi Health vs Zepbound
$164
★ 8.6
vs
$450
★ 9.3
Midi Health vs Mounjaro
$164
★ 8.6
vs
$1080
★ 9.2
Midi Health vs Wegovy Pill
$164
★ 8.6
vs
$149
★ 9.2
Midi Health vs Foundayo
$164
★ 8.6
vs
$149
★ 9.2
Midi Health vs Wegovy
$164
★ 8.6
vs
$349
★ 9.1
Midi Health vs NovoCare Pharmacy
$164
★ 8.6
vs
$149
★ 9
Midi Health vs Ozempic
$164
★ 8.6
vs
$349
★ 8.9
Midi Health vs Form Health
$164
★ 8.6
vs
$299
★ 8.8
Midi Health vs Henry Meds
$164
★ 8.6
vs
$179
★ 8.7
Midi Health vs Sesame Care
$164
★ 8.6
vs
$59
★ 8.7
Midi Health vs FuturHealth
$164
★ 8.6
vs
$225
★ 8.7
Midi Health vs Circle Medical
$164
★ 8.6
vs
$35
★ 8.7
Midi Health vs Ro
$164
★ 8.6
vs
$149
★ 8.6
Midi Health vs Noom Med
$164
★ 8.6
vs
$149
★ 8.6
Midi Health vs Precision Telemed
$164
★ 8.6
vs
$150
★ 8.6
Midi Health vs Hims
$164
★ 8.6
vs
$298
★ 8.5
Midi Health vs Calibrate
$164
★ 8.6
vs
$199
★ 8.5
Midi Health vs PlushCare
$164
★ 8.6
vs
$20
★ 8.5
Midi Health vs LifeMD
$164
★ 8.6
vs
$199
★ 8.5
Compare other providers
Compare GLP-1 Brands
vs